Mesalazine induced exacerbation of ulcerative colitis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8537058.
- Also identified by PMC identifier 1382949.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
5-Aminosalicylic acid (5-ASA) compounds occasionally exacerbate diarrhoea in patients with inflammatory bowel disease. This is thought to be due to a secretory mechanism in most cases. A patient with presumed intolerance to sulphasalazine and 5-ASA preparations who developed endoscopic and histological evidence of disease relapse after a rectal challenge with mesalazine is reported.
Medical subject headings
- Aminosalicylic Acids
- Anti-Inflammatory Agents, Non-Steroidal
- Colitis, Ulcerative